MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 141 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,397,300 | -33.9% | 57,500 | +4.5% | 2.76% | -34.1% |
| Q2 2023 | $12,705,000 | +74.8% | 55,000 | +83.3% | 4.19% | +95.3% |
| Q1 2023 | $7,268,000 | +25.2% | 30,000 | +50.0% | 2.15% | -13.3% |
| Q4 2022 | $5,805,000 | +257.2% | 20,000 | -20.0% | 2.48% | +443.4% |
| Q3 2022 | $1,625,000 | +1508.9% | 25,000 | +2677.8% | 0.46% | +1132.4% |
| Q4 2018 | $101,000 | -96.7% | 900 | -93.7% | 0.04% | -94.3% |
| Q3 2018 | $3,041,000 | -53.7% | 14,200 | -39.6% | 0.65% | -66.6% |
| Q2 2018 | $6,573,000 | – | 23,500 | – | 1.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
| University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
| Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
| TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
| Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
| Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
| Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
| Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
| MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
| Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |